nifedipine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with nifedipine could improve the apomorphine-induced rotation behavior in 6-OHDA-lesioned rats." | 1.38 | L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats. ( Ma, Z; Wang, J; Wang, R; Xie, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, R | 1 |
| Ma, Z | 1 |
| Wang, J | 1 |
| Xie, J | 1 |
1 other study available for nifedipine and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Calcium Channel Blockers; Calcium Channels, L-Type; Dopa | 2012 |